Ventricular Arrhythmias
24
5
7
12
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.2%
1 terminated out of 24 trials
92.3%
+5.8% vs benchmark
13%
3 trials in Phase 3/4
25%
3 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (24)
Cardiac Sympathetic Denervation in Patients With Refractory Arrhythmic Storm: a Single-center Case Series
Do QT-Prolonging Drugs Cause Major Adverse Cardiac Events in Hospitalized Adults?
Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm
PRIMARY Ancillary Substudy
Symptoms and Coping Strategies Among Patients With Implantable Cardioverter Defibrillator
Transcutaneous Vagus Nerve Stimulation for Ventricular Arrhythmias
Ultra High Resolution CT to Assess Role of Intramyocardial Fat and Delayed Enhancement in Ventricular Arrhythmogenesis
Impact of Catheter Ablation of Frequent Premature Ventricular Complexes in Treating Subtle Left Cardiomyopathy
Evaluation of Electrocardiographic Measurements by High Density Electrode ECG
Hybrid Score to Predict OTVA-SOO in Patients with Wide Basal QRS
A PRospective, rAndomizEd Comparison of subcuTaneOous and tRansvenous ImplANtable Cardioverter Defibrillator Therapy
Evaluation of Novel Biomarkers to Improve Risk Stratification and Patient Selection in Implantable Cardioverter-defibrillator (ICD) Therapy
Antiarrhythmic Effects of Spironolactone in Patients With ICDs
Scandinavian Multicenter Study to Advance Risk Stratification in Heart Disease- Ventricular Arrhythmias
Ventricular Arrhythmias After Pulmonary Vein Isolation
Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT)
Acute Study to Collect Electrical Signals From the Heart Using a Special Lead
Multimodal Image Processing Software to Guide Cardiac Ablation Therapy
Acute Defibrillation Study
Acute Subcutaneous Defibrillation